Company Premier Biomedical Inc OTC Bulletin Board
Equities
US74048K1043
Specialty Chemicals
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabe Vlad
DFI | Director of Finance/CFO | - | - |
William Tynan
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - | |
Carl Eller
SAM | Sales & Marketing | - | 15/11/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 133,780 | 0 | 0 | 99.00 % |
Stock B | 1 | 1,098,879,075 | 1,087,891,076 ( 99.00 %) | 0 | |
Stock C | 0 | 2,000,000 | 0 | 0 |
Company contact information
Premier Biomedical, Inc.
2409 Sycamore Drive
37921, Knoxville
+724 633 7033
http://www.premierbiomedical.comSales per Business
1st Jan change | Capi. | |
---|---|---|
+17.07% | 66.31B | |
-0.29% | 48.46B | |
+21.61% | 43.27B | |
+26.72% | 27.41B | |
+9.25% | 19.26B | |
-2.14% | 16.61B | |
+9.75% | 16.58B | |
-15.01% | 14.41B | |
-30.22% | 14.02B |
- Stock Market
- Equities
- BIEI Stock
- Stock
- Company Premier Biomedical Inc